Regine Sitruk-Ware

No ORCID on file · 6 papers in corpus
review 2010
Contraception ·doi:10.1016/j.contraception.2010.04.004

The synthetic progestins used for contraception so far are structurally related either to testosterone (estranes and gonanes) or to progesterone (pregnanes and 19-norpregnanes). Several new progestins have been designed to minimize side-eff…

lab-animal 2009
Contraception ·doi:10.1016/j.contraception.2009.11.004

BACKGROUND: Ulipristal (UPA; CDB-2914) is a progesterone receptor modulator with contraceptive potential. To test its effects when delivered by an intrauterine system (IUS), we prepared control and UPA-filled IUS and evaluated their effects…

review 2008
Maturitas ·doi:10.1016/j.maturitas.2008.11.011

The synthetic progestins used so far for contraception and menopausal hormone therapy are derived either from testosterone (19-nortestosterone derivatives) or from progesterone (17-OH progesterone derivatives and 19-norprogesterone derivati…

review 2005
Human Reproduction Update ·doi:10.1093/humupd/dmi046

The progestins have different pharmacologic properties depending upon the parent molecule, usually testosterone or progesterone (P), from which they are derived. Very small structural changes in the parent molecule may induce considerable d…

rct 2004
Human Reproduction ·doi:10.1093/humrep/deh420

BACKGROUND: Many techniques have been developed to soften the cervix to reduce complications following surgical dilatation. Progesterone inhibits myometrial contractility and its secretion during pregnancy ensures cervical competence. We us…

review 2004
Maturitas ·doi:10.1016/j.maturitas.2004.01.001

The synthetic progestins used so far for contraception and menopausal hormone therapy are derived either from testosterone (19-nortestosterone derivatives) or from progesterone (17-OH progesterone derivatives and 19-norprogesterone derivati…